ED
GSV

Exane Derivatives’s Gold Standard Ventures Corp. GSV Stock Holding History

Exane Derivatives’s Portfolio GSV Stock Details GSV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-11,893
Closed -$9.33K – 877
2020
Q3 		$9.33K Hold
11,893
– – ﹤0.01% 468
2020
Q2 		$9.82K Hold
11,893
– – ﹤0.01% 416
2020
Q1 		$5.76K Hold
11,893
– – ﹤0.01% 446
2019
Q4 		$8.88K Hold
11,893
– – ﹤0.01% 418
2019
Q3 		$9.24K Hold
11,893
– – ﹤0.01% 437
2019
Q2 		$12.4K Hold
11,893
– – ﹤0.01% 447
2019
Q1 		$12.1K Hold
11,893
– – ﹤0.01% 382
2018
Q4 		$14.9K Hold
11,893
– – ﹤0.01% 443
2018
Q3 		$20.2K Hold
11,893
– – ﹤0.01% 417
2018
Q2 		$16.2K Buy
+11,893
New +$18.2K ﹤0.01% 441

Other funds holding GSV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
SVG
Sun Valley Gold Sun Valley, Idaho $63.2M AUM 182.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LC
Loews Corp New York $11.9B AUM 8.99% 1-Year Est. Return
SI
Sprott Inc Toronto, Ontario, Canada $3.44B AUM 125.26% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
TCA
Transcend Capital Advisors Madison, New Jersey $1.25B AUM 17.69% 1-Year Est. Return

Exane Derivatives's GSV Position: Q4 2020 in Review

Exane Derivatives sold out of Gold Standard Ventures Corp. (GSV) in Q4 2020, closing a stake of 11,893 shares — an estimated $9.33K sold.

Exane Derivatives first reported a position in GSV in Q2 2018 and held it in 10 quarters. The position peaked at $20.2K in Q3 2018. 44 funds tracked by Wall St. Rank hold GSV as of Q4 2020.

  • Exane Derivatives reported no remaining Gold Standard Ventures Corp. position as of Q4 2020 after selling out during the quarter.
  • Exane Derivatives sold 11,893 Gold Standard Ventures Corp. shares in Q4 2020, an estimated $9.33K.
  • Exane Derivatives first reported a position in Gold Standard Ventures Corp. in Q2 2018 and held it in 10 quarters.
  • Exane Derivatives's Gold Standard Ventures Corp. position peaked at $20.2K in Q3 2018.
  • 44 funds tracked by Wall St. Rank held Gold Standard Ventures Corp. as of Q4 2020.

Based on Exane Derivatives's 13F filing for Q4 2020, filed 27 Jan 2021.